期刊
NUTRITION
卷 45, 期 -, 页码 125-134出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.nut.2017.06.024
关键词
Probiotic; Microbiota; Gastrointestinal conditions; Diarrhea; Inflammatory bowel disease; Liver disease
资金
- National Institutes of Health (NIH) from the National Center for Complementary and Integrative Health (NCCIH) [R24 AT001293]
- University of Maryland School of Medicine Summer Program in Obesity, Diabetes, and Nutrition Research Training (NIH) [T35 DK095737]
- National Center for Complementary & Integrative Health [R24AT001293] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK095737] Funding Source: NIH RePORTER
Alterations in the composition of the gut microbiota are associated with a number of gastrointestinal (GI) conditions, including diarrhea, inflammatory bowel diseases (IBD), and liver diseases. Probiotics, live microorganisms that may confer a health benefit to the host when consumed, are commonly used as a therapy for treating these GI conditions by means of modifying the composition or activity of the microbiota. The purpose of this review was to summarize the evidence on probiotics and GI conditions available from Cochrane, a nonprofit organization that produces rigorous and high-quality systematic reviews of health interventions. Findings from this review will help provide more precise guidance for clinical use of probiotics and to identify gaps in probiotic research related to GI conditions. (C) 2017 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据